Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Oral Oncol. 2015 Aug 14;51(10):957–962. doi: 10.1016/j.oraloncology.2015.07.011

Table 3.

Spearman’s rho correlation of palliative response with patient and clinical factors Palliation achieved? (0=no, 1=yes)

n Correlation
Coefficient
Sig. (2-
tailed)
Age (years) 75 0.10 0.383
KPS 75 −0.10 0.414
Histology (SCC, salivary, thyroid,
sarcoma, other)
75 −0.17 0.141
T1-2 vs T3-4 65 −0.03 0.834
N0-1 vs N2-3 75 0.01 .952
Prior RT to treated site 75 −0.03 0.77
Surgery to primary site 75 −0.13 0.287
Chemotherapy as part of palliative
treatment
75 0.15 0.187
Chemotherapy concurrently with at least
1 cycle of RTOG 8502
75 0.04 0.743
Additional palliative RT to primary site 72 −0.03 0.836
Cycles of RTOG 8502 75 0.29 0.012a
a

p<=0.05

Abbreviations: KPS, Karnofsky Performance Status; RT, radiotherapy; RTOG, Radiation Therapy Oncology Group;